Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,006 | 2,640 | -396 | -6,142 | -2,535 |
| Depreciation Amortization | 30,661 | 22,274 | 23,031 | 26,706 | 7,142 |
| Accounts receivable | -17,301 | 209 | -5,594 | -6,569 | -3,215 |
| Other Working Capital | -32,423 | 12,513 | -12,350 | -9,088 | -1,945 |
| Other Operating Activity | 34,426 | 7,150 | 13,346 | 16,570 | 6,946 |
| Operating Cash Flow | $23,369 | $44,786 | $18,037 | $21,477 | $6,393 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,029 | -14,310 | -13,690 | -7,536 | -2,215 |
| Net Acquisitions | 399 | -125,377 | N/A | 1,035 | -72,940 |
| Investing Cash Flow | $-19,630 | $-139,687 | $-13,690 | $-6,501 | $-75,155 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 10,002 |
| Debt Issued | 100,000 | 45,000 | 2,496 | 75,000 | 55,022 |
| Debt Repayment | -111,451 | -46,463 | -9,177 | -47,437 | -4,115 |
| Common Stock Issued | 171,976 | 144,094 | 2,586 | 3,768 | 935 |
| Other Financing Activity | -1,059 | -50,672 | 0 | -57,202 | -3,351 |
| Financing Cash Flow | $159,466 | $91,959 | $-4,095 | $-25,871 | $58,493 |
| Exchange Rate Effect | N/A | -68 | 44 | N/A | N/A |
| Beginning Cash Position | 9,811 | 12,821 | 12,525 | 23,420 | 33,689 |
| End Cash Position | 173,016 | 9,811 | 12,821 | 12,525 | 23,420 |
| Net Cash Flow | $163,205 | $-3,010 | $296 | $-10,895 | $-10,269 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,369 | 44,786 | 18,037 | 21,477 | 6,393 |
| Capital Expenditure | -20,029 | -14,310 | -13,690 | -7,536 | -2,215 |
| Free Cash Flow | 3,340 | 30,476 | 4,347 | 13,941 | 4,178 |